BE2017C062I2 - - Google Patents

Info

Publication number
BE2017C062I2
BE2017C062I2 BE2017C062C BE2017C062C BE2017C062I2 BE 2017C062 I2 BE2017C062 I2 BE 2017C062I2 BE 2017C062 C BE2017C062 C BE 2017C062C BE 2017C062 C BE2017C062 C BE 2017C062C BE 2017C062 I2 BE2017C062 I2 BE 2017C062I2
Authority
BE
Belgium
Application number
BE2017C062C
Other languages
Dutch (nl)
Original Assignee
Genmab As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmab As filed Critical Genmab As
Publication of BE2017C062I2 publication Critical patent/BE2017C062I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE2017C062C 2005-03-23 2017-11-30 BE2017C062I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200500429 2005-03-23

Publications (1)

Publication Number Publication Date
BE2017C062I2 true BE2017C062I2 (en) 2025-12-03

Family

ID=50644285

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2017C062C BE2017C062I2 (en) 2005-03-23 2017-11-30

Country Status (12)

Country Link
KR (1) KR20140033240A (en)
BE (1) BE2017C062I2 (en)
DK (1) DK1866338T3 (en)
ES (2) ES2606762T3 (en)
HU (2) HUE030783T2 (en)
LT (2) LT2567976T (en)
NZ (2) NZ600059A (en)
PL (1) PL1866338T3 (en)
PT (2) PT2567976T (en)
RS (1) RS55442B1 (en)
SG (1) SG10201610317VA (en)
UA (2) UA98756C2 (en)

Also Published As

Publication number Publication date
SG10201610317VA (en) 2017-02-27
LT1866338T (en) 2017-01-25
NZ625944A (en) 2016-01-29
DK1866338T3 (en) 2017-01-02
KR20140033240A (en) 2014-03-17
ES2644982T3 (en) 2017-12-01
NZ600059A (en) 2016-01-29
PL1866338T3 (en) 2017-04-28
PT1866338T (en) 2016-12-14
UA116520C2 (en) 2018-04-10
UA98756C2 (en) 2012-06-25
ES2606762T3 (en) 2017-03-27
PT2567976T (en) 2017-10-19
HUE030783T2 (en) 2017-06-28
HUE034962T2 (en) 2018-03-28
RS55442B1 (en) 2017-04-28
LT2567976T (en) 2017-12-11

Similar Documents

Publication Publication Date Title
BE2025C533I2 (en)
BE2024C510I2 (en)
BE2023C529I2 (en)
BE2021C552I2 (en)
BE2021C557I2 (en)
BE2021C531I2 (en)
BE2021C519I2 (en)
BE2021C513I2 (en)
BE2020C531I2 (en)
BE2020C511I2 (en)
BE2020C004I2 (en)
BE2019C521I2 (en)
BE2019C503I2 (en)
BE2018C037I2 (en)
BE2018C035I2 (en)
BE2018C019I2 (en)
BE2018C016I2 (en)
BE2017C028I2 (en)
BE2017C007I2 (en)
BE2016C045I2 (en)
BE2016C022I2 (en)
BE2014C012I2 (en)
BE2014C057I2 (en)
BE2013C074I2 (en)
BE2013C073I2 (en)